UPMC Hillman Cancer Center (UPCI)
United States of America (USA)
1 December 2019 - 30 November 2020
Principal institution: University of Pittsburgh Medical Center (UPMC)
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for UPMC Hillman Cancer Center (UPCI) published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
35 | 3.69 |
Outputs by subject (Share)
Subject | Count | Share | |
---|---|---|---|
Life Sciences | 33 | 3.12 | |
Cancer Cell | 2 | 0.03 | |
Cancer Research | 1 | 0.09 | |
Cell Metabolism | 2 | 0.07 | |
Immunity | 2 | 0.15 | |
Journal of Clinical Investigation | 2 | 0.09 | |
Journal of Experimental Medicine | 1 | 0.30 | |
Molecular Psychiatry | 1 | 0 | |
Nature | 1 | 0 | |
Nature Communications | 7 | 0.64 | |
Nature Genetics | 1 | 0 | |
Nature Immunology | 3 | 0.51 | |
Nature Medicine | 1 | 0.05 | |
Nature Structural & Molecular Biology | 1 | 0.25 | |
PLOS Biology | 1 | 0.03 | |
Proceedings of the National Academy of Sciences of the United States of America | 2 | 0.18 | |
Science Advances | 2 | 0.18 | |
eLife | 3 | 0.54 | |
Physical Sciences | 5 | 0.79 | |
Chemistry | 1 | 0.14 |
Top articles by Altmetric score in current window
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics
2020-01-07
Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity
Nature Immunology
2020-07-13
Antitumor activity of crizotinib in lung cancers harboring a exon 14 alteration
Nature Medicine
2020-01-13
Affiliated joint institutions and consortia

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.